A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

NCT05941936 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: LM103

Sponsor

Suzhou BlueHorse Therapeutics Co., Ltd.